DISINFACTS Issue 02/2026 Ausgabe 3/2014 Wir forschen für den Infektionsschutz. www.bode-science-center.de BODE SCIENCE CENTER DESINFACTS Serie Hochrisikobereiche Abseits der Routine: Versorgung Frühgeborener DESINFACTS AUSGABE 01/2025 Sterillium®: 60 Jahre in sicheren Händen DESINFACTS Auftrag angenommen: Nachhaltigkeit im Gesundheitsschutz Von der Klinik ins Stadion: Hygiene ist nun ein Thema für die gesamte Gesellschaft. Was folgt daraus? DESINFACTS AUSGABE 02/2021 DESINFACTS 100 Jahre Desinfektionskompetenz für HARTMANN Jubiläumsausgabe Flächen im Fokus: Oberflächenreinigung und -desinfektion ist unverzichtbarer Bestandteil der Infektionsprävention. Innovationen erhöhen die Wirksamkeit. DESINFACTS AUSGABE 01/2022 Nach der Impfung: Was bleibt? SCIENCE CENTER DESINFACTS AUSGABE 01/2021 DESINFACTS Mit umfassenden Wirksamkeitsnachweisen und einer wissenschaftsbasierten Forschung und Entwicklung, gewährleisten wir bei unseren Produkten zur Hygiene und Desinfektion einen bestmöglichen Qualitätsstandard. Wir forschen für den Infektionsschutz. Ausgabe 2/2012 Special: Gram-negative Erreger Weitere Themen: n HygieneVO der Länder n Mittags-Symposium zur Krankenhaushygiene DISINFACTS 1995-2026 Ausgabe 2/2017 Immer offen für neue Ideen. DESINFACTS Ausgabe 3/2017 Digitalisierung: Chancen erkennen und nutzen. DESINFACTS DESINFACTS AUSGABE 01/2026 15 Jahre HARTMANN SCIENCE CENTER Digital schützt besser! Mit automatisiertem Händehygiene-Monitoring Infektionsrisiken senken DESINFACTS AUSGABE 02/2022 SONDERAUSGABE 2023 DESINFACTS GREEN DESINFACTS AUSGABE 02/2025 Umfassende Hygiene-Lösungen für die ambulante Versorgung
EDITORIAL 03 FORUM Nearly 30 Years of DISINFACTS: Evolving with the Times 10 HARTMANN in the media: Article in the Süddeutsche Zeitung Dossier 23 Subscribe to the newsletter 24 KNOWLEDGE Reduced bacterial susceptibility to antiseptics 04 Healthcare-associated infections in long-term care 06 Skin health in the healthcare sector 14 Delphi consensus on the use of polyhexanide solution 16 Scrub or Rub? Rethinking Surgical Hand Disinfection 19 PRACTICE Future-proof for generations 12 STUDIES How can intensive care units meet future challenges? 08 Interlaboratory test lays the groundwork for a possible amendment to the standard 18 Study on the effect of hygiene measures in the home care setting 20 Identification of post-operative wound infections 21 Routine care of preterm and newborn infants 22 Content 2
Editorial DISINFACTS 2|2026 Dr. Heide Niesalla Dear readers, This issue marks the end of DISINFACTS in its current form. In future, we will provide our information increasingly via digital channels, keeping you up to date with the latest developments in infection prevention, surface disinfection and hand hygiene. Above all, this means one thing for you: You’ll get relevant content faster. You can continue to rely on us to keep you up to date via our email newsletters, the HARTMANN SCIENCE CENTER website, and our trusted services, such as the contact point and symposia. For many years, DISINFACTS has addressed current topics and facilitated professional dialogue with healthcare professionals. This dialogue has always been an important part of our work, and it will continue to be so in future. Looking back at the magazine’s history has shown us just how many developments and innovations we have supported together. At the same time, the demands placed on communication have changed. New scientific findings and up-to-date information are now continuously available. Digital formats allow us to share this content with you promptly, flexibly, and precisely. This is why, in future, we will focus our communication even more strongly on these channels. We would like to thank you sincerely for your interest in and loyalty to DISINFACTS. We are pleased to announce that, starting in January 2027, we will be introducing a new DISINFACTS newsletter format. We hope you enjoy reading this final issue. We look forward to staying in touch with you. Yours, Dr. Heide Niesalla Head of HARTMANN SCIENCE CENTER DISINFACTS, Issue 1/2024 DISINFACTS, Issue 2/2019 DISINFACTS, Issue 3/2017 DISINFACTS, Issue 1/2023 3
Broad clinical use of CHG CHG has been used in the medical field for decades, with concerns about reduced susceptibility only emerging recently. The substance has a broad antimicrobial spectrum of activity: it has a bactericidal effect at high concentrations and inhibits growth and reproduction at lower concentrations. In hospitals, CHG is commonly used for skin antisepsis in patients, particularly in the Anglo-American region, and for staff hand hygiene. Other clinical applications include antiseptic washing for residents of long-term care facilities, and the use of CHG as a mouthwash to treat gum inflammation. Furthermore, CHG is widely used in veterinary medicine [2]. CHG residues may persist in the hospital environment The study used controlled microcosm experiments to replicate the natural environment on a small scale. Although the concentration of CHG on all cleaned surfaces decreased significantly after 24 hours, it remained detectable in residual concentrations. The findings suggest that CHG can transfer from the skin to the surrounding environment and persist on surfaces despite cleaning and disinfection, often in sublethal concentrations (i.e. concentrations that do not kill clinically relevant bacteria). Among the bacteria with reduced sensitivity to CHG were opportunistic pathogens such as Pseudomonas aeruginosa. Washbasin drains in particular were found to be critical hotspots, and indoor air was identified as a possible transmission route [2]. Clinically relevant pathogens can survive CHG treatment The researchers also investigated how long four clinically relevant bacterial isolates – Escherichia coli, Klebsiella pneumoniae, Klebsiella variicola and Staphylococcus aureus – survive on plastic surfaces after being exposed to CHG for 24 hours. Five CHG concentrations corresponding to typical residual levels following cleaning or disinfection were tested. The results showed that all bacterial species survived for 24 hours on the treated surfaces, regardless of bacterial density and CHG concentration (Fig. 1). As exposure to sublethal concentrations of CHG has been linked to reduced susceptibility not only to CHG, but also to antibiotics, these findings are concerning [2]. Practical implications for hospitals The findings suggest that the widespread use of CHG should be critically reviewed, with unnecessary exposure being avoided. However, given the high clinical importance of CHG, appropriate stewardship measures and further research into alternatives are also required [2]. Bacteria can become less susceptible to antiseptics, which is a growing challenge for infection prevention. This is particularly the case for cationic, amphiphilic active substances such as quaternary ammonium compounds (QACs) or chlorhexidine digluconate (CHG). These substances can stimulate the production of non-specific efflux pumps in bacteria, which expel toxic substances such as QACs or CHG from the cell. Furthermore, these pumps enable bacteria to excrete certain antibiotics as well [1]. A recent study examined several potential risks associated with CHG use [2]. Reduced bacterial susceptibility to antiseptics: a growing concern Reconsidering the widespread use of chlorhexidine KNOWLEDGE 4
Fig. 1: Clinically relevant bacteria can survive 24-hour exposure to low-dose CHG on surfaces (modified from [2]). CHG = chlorhexidine digluconate; CFU = colony-forming units. Sources 1. Krewing M et al. (2024) J Hosp Infect 150: 51–60. https://doi.org/10.1016/j.jhin.2024.05.006. 2. Shen J et al. (2026) Environ Sci Technol 60: 10624–10639. https://doi.org/10.1021/acs.est.5c18587. 3. Kramer A et al. (2026) J Hosp Infect 170: 139–151. https://doi.org/10.1016/j.jhin.2026.01.008. 106 105 104 103 102 101 100 Cultivable bacteria (KBE/cm2) 0 0.31 3.1 15.5 31 Klebsiella variicola (20-20012) 0 0.31 3.1 15.5 31 Klebsiella pneumoniae (ATCC13883) 0 0.31 3.1 15.5 31 Escherichia coli (ATCC25922) 0 0.31 3.1 15.5 31 Staphylococcus aureus (ATCC29213) CHG concentration (ug/cm2) Key points at a glance • Widespread and repeated use of CHG can promote the development of reduced susceptibility in bacteria. • Hospitals should carefully review the use of CHG and avoid unnecessary exposure. KNOWLEDGE 5
WISSEN Healthcare-associated infections in long-term care A growing challenge Of particular concern is the fact that a significant proportion of clinically relevant pathogens, such as Acinetobacter baumannii and Pseudomonas aeruginosa, are already resistant to several classes of antibiotics in long-term care facilities – a trend that has intensified in recent years [2]. Risk factors for colonisation with multidrug-resistant pathogens include old age, dementia, chronic wounds, the use of medical devices such as urinary catheters, previous courses of antibiotic treatment, and high care dependency [2]. These data underscore the urgent need to implement effective infection prevention measures in longterm care facilities. Healthcare-associated infections (HAI) in long-term care facilities are becoming an increasingly significant issue, primarily due to an ageing population and an increased proportion of care home residents. According to the latest point prevalence study by the European Centre for Disease Prevention and Control (ECDC), HAI prevalence in European long-term care facilities was 3.1% in 2023–2024. Germany remained below the European average at 0.9%. Almost half of all HAI are respiratory and urinary tract infections Due to a variety of factors, residents of care homes are particularly vulnerable to HAI. General risk factors include disorientation, reduced mobility, incontinence and the presence of urinary or vascular catheters. A 12-month longitudinal study across nine European countries [2] showed that, between 2022 and 2023, 57% of residents in long-term care facilities contracted at least one HAI. The most common infection was respiratory tract infections (28.9%), comprising pneumonia Fig. 1: Relevant pathogens in long-term care. 1 Where pathogens are detected in the respiratory tract or in the event of a respiratory tract infection. 2 Differing recommendations in various guidelines. The guidelines of your own facility take precedence. 3 In the event of vomiting or severe diarrhoea [1]. * Defined by the US Centres for Disease Control and Prevention (CDC) as ‘urgent’ or ‘serious threats’ (as at 2 June 2025) 4 In accordance with facility-specific regulations. 5 Additional handwashing with soap and water. Important pathogens in long-term care facilities Please always observe your local hygiene plans and the requirements of occupational health and safety! Hygiene measures may vary in risk areas and in the event of an outbreak. Pathogen Category Spectrum of activity Main route of infection Hygiene measures Typical symptoms/clinical picture Suitable product 4-MRGN Acinetobacter baumannii * bactericidal 1 Catheter-associated urinary tract infections and pneumonia, wound and soft-tissue infections, sepsis Bacillol® 30 Sensitive Green Tissues Candidozyma auris * (formerly: Candida) yeasticidal 2 Candidiasis, Candidaemia 4-MRGN Enterobacter spp. * bactericidal 1 Wound infections, catheter-associated urinary tract infections, respiratory tract infections 4-MRGN Escherichia coli* bactericidal 1 Enteritis 4-MRGN Klebsiella pneumoniae* bactericidal 1 Nosocomial pneumonia, urinary tract infections, sepsis Methicillin-resistant S. aureus (MRSA) * bactericidal Sepsis, cellulitis, boils, impetigo contagiosa Norovirus limited spectrum virucidal activity 3 Gastroenteritis 4-MRGN Pseudomonas aeruginosa* bactericidal 1 Catheter-associated urinary tract infections, nosocomial pneumonia, wound infections, sepsis Respiratorisches syncytial virus (RSV) virucidal activity against enveloped viruses Respiratory tract infections, middle ear infections SARS-CoV-2 virucidal activity against enveloped viruses Pneumonia, enteritis, meningitis Vancomycin-resistant Enterococci (VRE) * bactericidal 4 Catheter-associated urinary tract infections, wound infections, rarely: endocarditis Clostridioides difficile* sporicidal (C. difficile) 5 Clostridioides-difficile-associated diarrhea (CDI) Bacillol® Oxy Tissues Hygienic measures Personal Protective Equipment (PPE) Basic hygiene (hands and surface) ( ) Use PPE in a targeted and situational manner. Depending on the risk of contamination, gloves, protective gowns, face masks or safety goggles may be required, regardless of the pathogen. Examples: Contact with blood, secretions/excretions, extensive wound care Contact protection measures/contact isolation ( ) Use disposable med. gloves and protective gowns. Depending on the pathogen and clinical picture, protective goggles and a face mask may also be required. Examples: MRSA, Clostridioides difficile Droplet isolation (short-range transmission) ( ) Use disposable med. gloves, protective gowns and face mask. Depending on the pathogen and clinical picture, protective goggles may also be required. Aerogenic isolation (long-range transmission) ( ) Use disposable med. gloves, protective gown, respirator (e. g. FFP-2). Depending on the clinical picture, protective goggles may be required. 1. Pathogen detected in respiratory tract/respiratory tract infection 2. Different recommendations from different guidelines. The guidelines of your institution are decisive. 3. With vomiting or pronounced diarrhea 4. According to facility-specific specifications 5. Additional hand washing with soap and water Source: ECDC (2025) Point prevalence survey of healthcare-associated infections and antimicrobial use in European long-term care facilities 2023-2024. * defined by the U.S. Centers for Disease Control and Prevention (CDC) as “urgent” or “serious threats” (as of June 2, 2025) Use disinfectants safely. Always read the label and product information before use. (08.26) Legend Bacteria Spores Enveloped viruses Non-enveloped viruses Yeasts/fungi Droplets or aerosols, mainly short-range transmission Droplets or aerosols, relevant long-range component Direct contact Indirect contact Food and water Basic hygiene Contact protection measures/ contact isolation Droplet isolation (short-range transmission) Aerogenic isolation (long-range transmission) Gloves Protective gown Mask Protective goggles Respirator (e. g. FFP-2) Find our products here Your pathogen is not listed? Take a look at our pathogen search KNOWLEDGE 6
(7.3%) and other lower respiratory tract infections (10.7%). Urinary tract infections were the second most common infection, accounting for 18.7% of cases. This was followed by recorded cases of SARS-CoV-2 (17.6 per cent) and skin and soft tissue infections (14.3%). Of those affected, 4.3% required hospitalisation and 4.5% of the infections were fatal [2]. Relevant pathogens are often linked to resistance The World Health Organization (WHO) regularly updates its list of the most relevant bacterial pathogens (WHO Bacterial Priority Pathogens List) [4] to help health systems adapt their prevention measures. Gram-negative bacteria that are resistant to reserve antibiotics are currently classified as being of particular concern. Examples include carbapenem-resistant Acinetobacter baumannii and Enterobacterales resistant to carbapenems and/or third-generation cephalosporins, often referred to as ‘4-MRGN’. Other high-priority bacteria include vancomycin-resistant enterococci (VRE), methicillinresistant Staphylococcus aureus, and carbapenem-resistant Pseudomonas aeruginosa [4]. Of particular significance is their ability to survive for long periods on surfaces. Some of these bacteria can persist on surfaces for months or even years. For example, Pseudomonas aeruginosa can survive on surfaces for up to 16 months, enterococci for up to 4 months, and Acinetobacter for up to 5 months [5]. This has far-reaching implications for the required surface hygiene measures. Preventing HAI in long-term care facilities: what works? Effective hand hygiene and thorough surface cleaning are also crucial in long-term care facilities to curb the spread of nosocomial infections. Additional contact precautions, or even droplet or airborne isolation, are necessary for certain pathogens. Our pathogen table (Fig. 1) shows at a glance which measures are required for each specific pathogen. Available for download as a poster and as a handy pocket card from the HARTMANN SCIENCE CENTER website. Sources 1. European Centre for Disease Prevention and Control (2025) Point prevalence survey of healthcare-associated infections and antimicrobial use in European long-term care facilities 2023–2024. ECDC; Stockholm. https://www.ecdc.europa.eu/sites/default/files/ documents/PPS-HAI-AMR-LCTF.pdf (accessed on 18 August 2026) 2. Rodríguez-Villodres Á et al. (2021) Antibiotics (Basel) 10: 680. https://doi.org/10.3390/ antibiotics10060680. 3. Ricchizzi E et al. (2025) Lancet Infect Dis 25: 1199–1207. https://doi.org/10.1016/S14733099(25)00217-8. 4. World Health Organisation (2024) WHO List of Priority Bacterial Pathogens. WHO; Geneva. https://www.who.int/publications/i/item/9789240093461 (accessed 18 August 2026) 5. Kramer A et al. (2006) BMC Infect Dis 6: 130. https://doi.org/10.1186/1471-2334-6-130. KNOWLEDGE 7
STUDIES The Intensive Care Unit of the Future How can intensive care units meet future challenges? The focus was on preventing hospital-acquired infections, optimizing workflows, and creating sustainable ward structures. These findings aim to reduce infection rates, improve working conditions, and support the delivery of efficient and sustainable intensive care. Industry partners also contributed their practical expertise, including the HARTMANN SCIENCE CENTER, which focused on two key areas: sustainability and digital infection prevention. Material consumption and sustainability in intensive care units Healthcare systems worldwide are a significant contributor to climate change. Healthcare accounted for an estimated 4.4% of global greenhouse gas emissions in 2014 [2]. At the same time, climate change is having an impact on public health, leading to an increased demand for healthcare services. Therefore, in recent years, awareness of the need for climate protection measures in the healthcare sector has grown [3]. This is particularly relevant for intensive care units, which have a problematic environmental footprint [4]. Using sustainable materials, reducing waste and adopting environmentally friendly technologies can help to protect the environment and conserve resources. However, this must not compromise patient safety or the quality of care. As implementation depends on factors such as climate, the legal framework and local conditions, it is only possible to implement one-size-fits-all solutions to a limited extent. Digital solutions and electronic monitoring systems Although up to 90% of pathogens in the healthcare sector are transmitted via the hands [5], there is room for improvement in hand hygiene compliance (HHC) [6]. In Germany, around 600,000 patients are affected by nosocomial infections (NIs) each year [7], incurring costs of approximately €2 billion [8]. Digital solutions and monitoring systems could play a vital part in reducing HAIs in intensive care units by optimizing HHC, automatically identifying infection clusters and ensuring environmental cleaning. To make optimal use of existing digital systems in future, structural or infrastructural measures may be required. Integrating artificial intelligence (AI) could offer further potential, particularly in pattern recognition, surveillance, and the early identification of infection risks. Germany’s intensive care units are facing an increasing number of challenges due to rising demand for care, greater treatment complexity, heavy workloads, infection risks, and a shortage of skilled staff. The ‘Intensive Care Unit of the Future’ consortium project [1] investigated key future challenges for intensive care units and developed new approaches to address them. Sources 1. Sunder W et al. (2026) The Intensive Care Unit of the Future. Guide: Planning and Development of Structural and Process-Based Model Solutions for Intensive Care Units. BBSR Online Publication 18/2026. Bonn. https://doi.org/10.58007/sa1h-2x96 2. Karliner Josh et al. (2019) Health Care’s Climate Footprint: How the Health Sector Contributes to the Global Climate Crisis and Opportunities for Action. https://noharm- global.org/sites/default/files/documents-files/5961/HealthCaresClimateFootprint_092319.pdf (accessed on 5 August 2026) 3. Federal Ministry of Health (2022) Climate Pact for Health. https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloads/G/Gesundheit/Erklaerung_ Klimapakt_Gesundheit_A4_barrierefrei.pdf (accessed on 5 August 2026) 4. Prasad PA et al. (2022) Environmental footprint of regular and intensive inpatient care in a large US hospital. Int J Life Cycle Assess 27: 38–49. https://doi.org/10.1007/ s11367-021-01998-8. 5. Kramer A (2006) Hand hygiene – protection of patients and staff. GMS Krankenhaushyg Interdiszip 1: Doc14. https://www.egms.de/static/en/journals/dgkh/2006-1/ dgkh000014.shtml (accessed on 6 August 2026) 6. KRINKO (2016) Hand hygiene in healthcare settings. Bundesgesundheitsbl 59: 1189–1220. https://doi.org/10.1007/s00103-016-2416-6. 7. Suetens C et al. (2018) Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill 23: 1800516. https://doi.org/10.2807/1560-7917. ES.2018.23.46.1800516. 8. Nachtigall I, Bonsignore M (2018) Economic implications of hygiene. Krankenhaushygiene up2date 13: 419–431. https://doi.org/10.1055/a-0749-6933 Key points at a glance: • Future-proof intensive care units must give equal consideration to sustainability and patient safety. • Digital solutions and AI open up new possibilities for more effective infection prevention and optimized workflows. * Karliner et al. (2019): Health care’s climate footprint: How the health sector contributes to the global climate crisis. Health Care Without Harm / ARUP. ** Crippa et al. (2024): CO₂ emissions of all world countries – JRC/IEA/PBL 2024 Report. If the global healthcare system were a country, it would rank fifth CO2 emissions** total Country Global Distribution in % 1 China 30.1 % 2 USA 11.3 % 3 India 7.8 % 4 Russia 5.0 % 5 Brasil 2.5 % 6 Indonesia 2.3 % 7 Japan 2.0 % 4.4 % of the global CO2 emissions* Healthcare system 8
STUDIES Glove disinfection in emergency situations An alternative to hand disinfection plus changing gloves? As changing gloves, including hand disinfection, is time-consuming, disinfecting examination gloves could represent a viable alternative [4]. Until now, however, there has been a lack of research into the integrity of disinfected medical examination gloves under realistic conditions. HARTMANN and the NOTIS e.V. Emergency Medicine Training Centre have now investigated the compatibility of gloves with a hand disinfectant, as well as the effect of mechanical stress on glove material, in a simulation study [5]. Peha-soft® Nitrile Fino examination gloves withstand disinfection in practical testing Thirteen healthcare professionals who were trained in accordance with the Basic Life Support and Advanced Cardiovascular Life Support standards, respectively, took part in the study. For half of the exercises, the Peha-soft® Nitrile Fino nitrile gloves were disinfected using Sterillium® med hand disinfectant. Once the exercises were complete, the worn gloves were collected and tested for barrier integrity in accordance with DIN EN 455-1:2024-11, Part 1 [6]. Of the 1,175 gloves tested – 606 untreated and 569 disinfected – 12 (1%) failed the test, including nine untreated and three disinfected gloves. This means Emergency situations, such as cardiopulmonary resuscitation (CPR), are characterized by significant time pressure. This often leads to infection control, particularly hand disinfection, being neglected [1]. However, recent studies show that hand disinfection could be performed in over half of cases without delaying CPR [2, 3]. Fig. 1: Number of gloves that passed and failed the test in accordance with DIN EN 455-1:2024-11; Part 1 [6]. Sources 1. Bushuven S et al. (2024) Int J Nurs Stud Adv 6: 100207. https://doi. org/10.1016/j.ijnsa.2024.100207. 2. Bushuven S et al. (2023) Front Med (Lausanne) 9: 1025449. https://doi. org/10.3389/fmed.2022.1025449. 3. Bentele M et al. (2024) Infect Prev Pract 7: 100418. https://doi. org/10.1016/j.infpip.2024.100418. 4. Scheithauer S et al. (2016) J Hosp Infect 94: 268–272. https://doi. org/10.1016/j.jhin.2016.08.007. 5. Bentele M et al. (2026) Integrity of medical examination gloves after disinfection - Results from Basic and Advanced Life Support; Poster presented at the DGHM Congress 2026. Available via HARTMANN SCIENCE CENTER: https://www.hartmann-science-center.com/en/topissues/events/dghm-2026 6. DIN EN 455-1:2024-11. Single-use medical gloves – Part 1: Requirements and testing for leak-tightness; German version of EN 455-1:2020+A2:2024. Key findings at a glance • In the tested setting, mechanical stress following disinfection with Sterillium® med had no effect on the barrier integrity of Peha-soft® Nitrile Fino examination gloves. • 99.5% of the disinfected gloves and 98.5% of the untreated gloves passed the DIN EN 455-1 test. • The results support the implementation of glove disinfection in emergency situations without compromising glove quality. • Although repeated disinfection affected mechanical properties, including force at break, the magnitude of these effects may vary between glove materials. Consequently, extrapolation to other examination gloves and hand disinfectants requires additional testing. AQL: Accepted Quality Limit (= permissible defect rate) The AQL specifies how many parts in a given sample size may have defects. The exact limit values for different sample sizes and batch sizes are set out in ISO 2859-1. In the European Union, disposable examination gloves have a standard AQL of 1.5. For a sample size of 200 gloves, this means a maximum of 7 defecte gloves to pass the test. The next better AQL value of 1.0 would, by definition, mean that there would be 5 defective gloves in a random sample of 200 gloves. ?! that 98.5% of the untreated gloves and 99.5% of the disinfected gloves were intact (see Fig. 1). The expected defect rate was below 3.5%, confirming the Acceptable Quality Limit (AQL) target of 1.5—both with and without glove disinfection. The Peha-soft® Nitrile Fino gloves tested here even have an AQL of 1.0 and, according to the standard definition, maintain this value even after disinfection. Direct comparisons revealed no differences in frequency of tears between groups, regardless of the hand on which the gloves were worn (right vs. left) or glove size. The findings of this study therefore support the efforts to ensure that hygiene is implemented correctly in emergency situations. native gloves 98.5 % disinfected gloves 99.5 % 9
FORUM Trusted Content, New Channels 30 Years of DISINFACTS: Evolving with the Times This commitment was clearly articulated from the very first issue. With the title ‚Facts on Disinfection‘, DISINFACTS aimed to highlight key developments in hygiene and disinfection, and promote professional exchange. The focus was always on topics directly relevant to day-to-day work in medical facilities. The magazine’s content also reflected the dynamic nature of developments in the field. DISINFACTS reported on new scientific findings, updated recommendations, and innovative procedures. One example of this was the debate surrounding the reduction in contact time for surgical hand disinfection. This demonstrates how standards evolve over time, with the aim of making infection prevention both effective and userfriendly. We are particularly pleased that our publication, EN 1500 in 15 Seconds 2024, is another step towards developing standards. In 2025, DISINFACTS celebrated its 30th anniversary. A look back at past issues, however, shows that standing still was never part of its concept. Since its first issue in 1995, the magazine has undergone constant change in terms of its design, the topics it covers and the ways in which it communicates. One thing has remained constant throughout: its commitment to providing healthcare professionals with up-to-date, practical information on hygiene and infection prevention. However, hygiene is not the only thing that has changed; communication has too. In the early 1990s, information was exchanged via reply cards, telephone or fax. Today, digital channels take centre stage. New scientific findings, guidelines and studies can be made available almost in real time, reaching professionals wherever they look for information. Our digital information services are already an integral part of the HARTMANN SCIENCE CENTER. As we continue to develop our communication services, they are taking an even more central role, ensuring that up-to-date specialist knowledge is available exactly where it is needed. 10
FORUM Bildbearbeitung Desinfacts Titel und Rückseite What has made DISINFACTS special for its readers over the years? ‘DISINFACTS has always sought to place scientific findings in a practical context. Our goal has been to do more than simply report research findings; we have aimed to contextualize their significance for day-to-day professional practice. At the same time, we have addressed topics that genuinely concern our readers. In my view, combining science and practice is one of the magazine’s particular strengths’ What content will continue to play an important role in the future? ‘The core topics will remain the same: infection prevention, hand and surface hygiene, the latest scientific findings, and practical solutions for day-to-day work in the healthcare sector. 3 Questions for Dr Heide Niesalla, Head of the HARTMANN SCIENCE CENTER Added to this are issues that have become increasingly important in recent years, such as sustainability, new forms of care, and the digital transformation of healthcare. We will continue to monitor and contextualize these developments.’ What are your hopes for the future of professional exchange with readers? ‘I hope that the dialogue will become even more direct. Digital formats allow us to respond more quickly to current topics and foster closer interaction. We continue to welcome questions, suggestions, and discussions from the field. After all, effective infection prevention does not arise solely from science, but also through dialogue with the people who apply this knowledge in their daily work.’ Pathogen profiles Key facts about pathogens at a glance: symptoms, routes of transmission, distribution, measures to prevent infection The pathogen search feature on the HARTMANN SCIENCE CENTER website now features a new, clearly structured layout. What type of pathogen is involved? How is it transmitted? What hygiene measures and personal protective equipment are required? What spectrum of activity must a disinfectant cover? This is supplemented by direct links to related technical articles. Pathogen search 2.0 11
For some products, BPR authorization represents the first instance of a comprehensive regulatory evaluation and authorization process, given that individual EU countries previously only required formal notification procedures. The authorization process is a two-stage procedure: first, each active substance undergoes a regulatory evaluation process. Subsequently, the relevant products must be authorized or adapted [1, 2]. Numerous active substances in disinfectants are being reevaluated As several active substances are being re-evaluated under the BPR, or may even be withdrawn, this could have implications for the entire disinfectant market. For instance, the authorization of ethanol under the BPR has been the subject of heated debate since 2007 due to conflicting risk assessment views. This has left manufacturers and customers uncertain as to whether ethanol-based hand disinfectants will remain usable in future, and in what form. One thing is certain: ethanol in hand disinfectants cannot simply be replaced by propanol. Formulations containing ethanol are the only ones that are sufficiently effective against non-enveloped viruses such as adenoviruses, rotaviruses and noroviruses within 30 to 60 seconds [3]. Future-proof for generations To provide users with guidance, we at HARTMANN have launched the #Driven by BPR campaign. For us, ‘Driven by BPR’ means seizing the regulatory changes brought about by the BPR as an opportunity for responsible and transparent progress that considers our customers’ needs. These requirements are more than mere regulatory guidelines to us. They reaffirm our long-standing commitment to developing and continuously refining safe, effective, scientifically sound disinfection solutions that are tailored to the needs of our customers and users. PRACTICE Future-proof for generations #Driven by BPR The EU Biocidal Products Regulation (BPR) is gradually changing the regulatory requirements for biocidal products, including hand and surface disinfectants, across Europe. The BPR aims to establish uniform standards, increase transparency, and ensure a high level of protection for humans, animals, and the environment. Goods/Textiles Private household MCC Hospital Emergency Medical Services Doctor‘s Office Wastewater treatment plant Industry / Commerce Biocides: Areas of use and potential routes of entry Water bodies Soil Groundwater Agricultural sector Leisure sector Disinfectants* Discharge to municipal sewage treatment works Discharge to industrial sewage treatment works Illustration based on a diagram from the GermanFederal Environment Agency * Disinfectants are listed here as an example of a type of biocide; the list of possible biocides and routes of entry is not exhaustive. 12
PRACTICE Reliability for our customers: we are prepared At HARTMANN, we take a proactive approach. By preparing well in advance for BPR authorization, we can avoid delays, secure market access and provide our customers with reliable support. We understand that regulatory changes can be complex and may require adjustments to formulations, product names, labels, item numbers or authorizations, for example. However, this should not cause our customers unnecessary concern. How do we ensure this? We carefully manage these adjustments, providing information about them early on in a transparent manner, and we offer our customers safe, effective and legally compliant disinfection solutions. Sources 1. https://echa.europa.eu/de/regulations/biocidal-products-regulation/understanding-bpr (accessed on 25 August 2026) 2. https://www.bvmed.de/themen/nachhaltigkeit/environmental-law-information-service/enviormental-law-overview-biocide-regulation (accessed on 25 August 2026) 3. Kramer A et al. (2023) GMS Hyg Infect Control 18: Doc02. https://doi.org/10.3205/dgkh000428. Key points at a glance: • The EU Biocidal Products Regulation (BPR) ensures a high level of protection for humans, animals and the environment. • HARTMANN is keeping pace with regulatory changes through the #DrivenByBPR campaign – transparently and with a focus on the customer. • Products such as Sterillium® pure are already BPR-approved and offer a reliable, effective and legally compliant solution. #Driven by BPR: Find out more on the campaign website and watch the video! https://www.hartmann. info/en/campaign/ disinfection/2026/bpr First HARTMANN products already BPR-authorized As part of the authorization process under the BPR, our first product range has already been approved: this includes Sterillium® pure, which received its authorization in October 2025. This colourant- and fragrance-free hand disinfectant can be used in all areas where hygiene is important and is suitable for people with sensitive skin, asthma or atopic conditions. Its good tolerability has been confirmed by the independent ECARF Institute. The first milestone is Sterillium® pure. The BPR-approved portfolio will gradually expand to include further products in 2027. 13
Occupational and economic consequences Hand eczema can have serious consequences. A Danish epidemiological study showed that 20% of people with work-related hand eczema took more than five weeks of sick leave per year due to the condition [5]. A long-term Swedish study found that up to 82% of patients had to change their employment situation because of the condition [6]. The economic consequences are also significant: in Germany, for example, productivity losses result in average costs of over €8,000 per patient per year [7]. Prevention through training and skin care However, there are effective methods of preventing hand eczema from developing in the first place. Training courses on improving skin care could be helpful, for example. This was the conclusion of a prospective, controlled intervention study involving healthcare professionals during the pandemic [8]. The intervention group received web-based health training and free access to hand cleansing and care products. After six months, no new cases of hand eczema had occurred in this group (n = 115), whereas 12 people (8.8%) in the control group (n = 136) were diagnosed with new hand eczema [8]. Fragrances as a risk factor The EDEN Fragrance study involved 3,119 participants from five European countries undergoing a patch test with various fragrance mixtures. The Europe-wide prevalence of fragrance allergy was conservatively estimated at 1.9% [9, 10]. As there are no medicines or desensitisation treatments for contact allergies, the only solution is to consistently avoid the triggering substances. Therefore, the S2k guideline ‘Occupational skin care products: skin protection, skin care and skin cleansing’ [11] advises against the use of numerous preservatives and fragrances in occupational skin care products. Skin health in the healthcare sector Challenges and Solutions Hand eczema is the most common non-infectious occupational disease among healthcare workers, affecting approximately one in five professionals in the sector [1,2]. During the COVID-19 pandemic, the number of cases presenting in dermatology practices increased significantly, impacting both healthcare professionals and the general population [3]. In Germany, around 90% of all occupational skin diseases classified as BK 5101 (“severe or recurrent skin diseases”) are cases of hand eczema [4], underscoring the considerable burden and relevance of this condition. In Germany, productivity losses result in average costs of over 8,000 € per patient per year [7]. Key points at a glance: • Hand eczema is the most common work-related skin condition in the healthcare sector, affecting around 20% of healthcare professionals. • The consequences range from high rates of sick leave to occupational disability. • Training in skin care, combined with the use of fragrance- and preservative-free hand sanitisers such as Sterillium® pure, can help to prevent the condition. KNOWLEDGE 14
Expert opinions: training and fragrance-free products PD Dr Richard Brans from iDerm Osnabrück estimates that 10–30% of healthcare professionals suffer from hand eczema, a problem he believes could be resolved through training. Provided they are free from colourants and fragrances, modern hand sanitisers are sufficiently skin-friendly and contain effective moisturising agents. Stefanie Link from the European Centre for Allergy Research Foundation (ECARF) confirms that alcohol-based hand sanitisers are generally well tolerated. She considers the main problem to be hand washing and also advises avoiding fragrances and preservatives, as well as skin contact with surface disinfectants. She also considers training on the correct use of skin protection and care to be an effective measure. Dr Andreas Conrad from the German Advisory Centre for Hygiene (BZH), however, believes that training alone is insufficient. He emphasises the importance of products containing skin-care complexes, but points out that these could also mobilise allergens from gloves. Sources 1. Hamnerius N et al. (2018) Br J Dermatol 178: 452–461. https://doi.org/10.1111/ bjd.15813. 2. Skudlik C et al. (2009) Contact Dermatitis 60: 136–143. https://doi.org/10.1111/ j.1600-0536.2008.01496.x. 3. Hardt W (2020) Dtsch Dermatolog 68: 412–413. https://pmc.ncbi.nlm.nih.gov/ articles/PMC7287288/pdf/15011_2020_Article_3216.pdf (accessed on 21 August 2026) 4. Herloch V, Elsner P (2021) J Dtsch Dermatol Ges 19: 720–742. https://doi. org/10.1111/ddg.14537_g. 5. Cvetkovski RS et al. (2005) Br J Dermatol 152: 93–98. https://doi.org/10.1111/ j.1365-2133.2005.06415.x. 6. Meding B et al. (2005) Contact Dermatitis 53: 308–313. https://doi.org/10.1111/ j.0105-1873.2005.00731.x. 7. Diepgen TL et al. (2013) Contact Dermatitis 69: 99–106. https://doi.org/10.1111/ cod.12038. 8. Symanzik C et al. (2022) Contact Dermatitis 87: 500–510. https://doi. org/10.1111/cod.14206. 9. Diepgen TL et al. (2015) Br J Dermatol 173: 1411–1419. https://doi.org/10.1111/ bjd.14151. 10. van Amerongen CCA et al. (2021) Contact Dermatitis 84: 385–394. https://doi. org/10.1111/cod.13807. 11. Gina M et al. (2026) J Dtsch Dermatol Ges 24: 700–711. https://doi.org/10.1111/ ddg.70005x. 12. https://isad.org/news/ad-essential-medicines-included-in-the-who-2025-lists (accessed on 21 August 2026) Healthy hands in everyday life Hand disinfectants without colourants or fragrances, such as Sterillium® pure, are suitable for sensitive and heavily used hands – whether in everyday life, whilst travelling or when caring for loved ones. Watch the video now: KNOWLEDGE 15
STUDIES Delphi consensus on the use of polyhexanide solution Antiseptic wound irrigation to reduce postoperative wound infections in orthopaedic surgery Surgical site infections (SSI) and periprosthetic joint infections (PJI) are common complications in orthopaedic surgery [1–3]. They are associated with significant morbidity and mortality, as well as imposing a heavy financial burden on the healthcare system [1–4]. In visceral surgery, antiseptic wound irrigation with polyhexanide (PHMB) prior to wound closure has been shown to significantly reduce the rate of SSIs compared with saline solution irrigation [5]. However, data from clinical trials on PHMB wound irrigation for SSI prevention in orthopaedic procedures is limited [1]. Recommendations for its use have now been developed as part of an Italian Delphi consensus [1]. The efficacy of antiseptic irrigation has been demonstrated with a high level of evidence In addition to mechanical debridement, wound irrigation is a standard surgical procedure for removing tissue, exudate and microorganisms [1]. This can be done using saline solution, as well as antibiotic or antiseptic solutions [1]. A recent systematic review and network meta-analysis of 41 randomized clinical trials demonstrates, with a high level of evidence, that antiseptic irrigation solutions are associated with a reduction in surgical site infections (SSI) compared with no irrigation. However, irrigation with saline solution showed no significant advantage over no irrigation [2]. Although antibiotic wound irrigation was also associated with fewer SSIs, the evidence for this was of low quality. Furthermore, the risk of developing antimicrobial resistance argues against its routine use [2]. Dual mechanism of action of PHMB/PLX wound irrigation In addition to well-known antiseptics such as povidone-iodine (PVP-I), there are now other antimicrobial solutions available for wound irrigation. One example is a dual-action irrigation solution containing PHMB and poloxamer (PLX), such as PREVENTIA® Surgical Irrigation [1]. PHMB penetrates bacterial cell membranes, eliminating biofilms and providing strong defence against harmful microbes [6]. PLX reduces the surface tension between materials, enabling PHMB to reach the site of action more efficiently [7]. Delphi consensus on use in orthopaedic surgery A panel of Italian experts from various disciplines, including orthopaedics, infectious diseases and plastic surgery, has developed recommendations based on consensus for the use of antiseptic irrigation solutions during surgery to prevent surgical has a broad spectrum of antimicrobial activity and is effective against biofilms. PHMB penetrates the cell membranes of bacteria, where it eliminates biofilms and provides robust protection against harmful microbes.1 Polyhexanide (PHMB) 16
STUDIES Sources 1. Indelli P et al. (2026) J Clin Med 15: 1718. 2. Groenen H et al. (2026) JAMA Surg 159(7): 792–800. 3. Davey MG et al. (2026) Am J Surg 256: 116930. 4. Strobel R et al. (2022) Langenbeck’s Archives of Surgery 407: 819–828. 5. Strobel R et al. (2020) Ann Surg 271(1): 55–64. 6. Kramer A et al. (2018) Skin Pharmacol Physiol 2018; 31(1): 28–58. 7. Percival S et al. (2018) Int Wound 15(5): 749–755. site infections (SSIs) in orthopaedic procedures, with a particular focus on PHMB/PLX [1]. Following a literature review, twelve statements were developed through two rounds of anonymous voting. This process achieved a strong consensus of 80% on a nine-point Likert scale [1]. Key patient-related risk factors for SSIs include active smoking and uncontrolled diabetes mellitus. Other risk factors include a BMI greater than 35 kg/m², malnutrition, and immunosuppression. Previous radiotherapy to the surgical site, a history of infections in the intervention area, recurrent soft-tissue infections and intra-articular therapy within three months prior to surgery also increase the risk of SSI [1]. Experts classify procedures performed due to osteomyelitis, infected prostheses, open fractures of grades 2 or 3, and oncological conditions as high-risk SSI procedures [1]. Recommendations for clinical practice For all procedures involving an increased risk of infection, antiseptic wound irrigation is recommended over saline solution irrigation or no irrigation at all [1]. Antibiotic irrigation solutions should be avoided due to the risk of resistance developing [1]. For all patients, especially those with at least one risk factor that is either patient-specific or procedure-related, using an antimicrobial irrigation solution containing PHMB/ PLX is recommended. For high-risk orthopaedic procedures, especially those involving infected areas, the use of a PHMB/ PLX irrigation solution is specifically recommended [1]. A sufficient volume of PHMB/PLX irrigation solution should be used to fill the entire surgical site. Irrigation should preferably be carried out at low pressure, particularly during trauma surgery [1]. As a preventive measure, the minimum contact time is one minute, whereas in an area where infection has already occurred, it is three minutes. Conclusion The Italian Delphi consensus recommendations provide a practical framework for the standardized, risk-adapted use of antimicrobial wound irrigation with PHMB/PLX to prevent postoperative wound infections. Further clinical studies are planned to evaluate its efficacy in orthopaedic surgery. 17
STUDIES EN 1500: Reduce contact time to 15 seconds? Interlaboratory test lays the groundwork for a possible amendment to the standard In practice, however, the actual rub-in times observed during hygienic hand disinfection are often significantly shorter than the specified 30 seconds [2]. An interlaboratory test organized by the Association for Applied Hygiene (VAH) investigated whether reducing the rubbing time to 15 seconds in the EN 1500 standard protocol is methodologically reliable and reproducible [2]. Fourteen laboratories from Germany, Austria, Italy and Malaysia participated in the interlaboratory test. They investigated a modified EN 1500 procedure involving 3 ml of 60% isopropanol and a rub-in time of 15 seconds. The established procedure involving 2 × 3 ml of 60% isopropanol and 2 × 30 seconds of rubbing time served as the reference. In a randomized crossover design, the participants’ hands were first artificially contaminated with Escherichia coli K12. Following hand disinfection, the reduction in bacterial count was determined [2]. In order to be suitable for hygienic hand disinfection, a disinfectant must demonstrate its bactericidal efficacy in accordance with EN 1500 standard using a reference method involving a standardized rubbing procedure and a minimum contact time of 30 seconds [1]. Efficacy was lower than that of the reference method Good reproducibility and repeatability were observed in all laboratories. Despite the shorter rubbing time, the method remained statistically stable. On average, however, the efficacy was lower than that of the reference method. In 13 out of 14 laboratories, lower log₁₀ reductions were achieved with a rubbing time of 15 seconds than with the reference method over 30 seconds. One laboratory reported comparable efficacy for both rubbing times. Carrying out the six-step rubbing technique in 15 seconds proved challenging. No significant influence of hand size on efficacy was observed. The interlaboratory test thus provides an important scientific basis for amending EN 1500 to reduce the rubbing time. However, further validation is necessary to ensure efficacy and user safety [2]. Sources 1. DIN EN 1500-2013: Chemical disinfectants and antiseptics – Hygienic handrub – Test method and requirements (phase 2/step 2). 2013. 2. Roesch KM et al. (2026) J Hosp Infect 171:227–235 Of all healthcare-associated infections (HAI), 85% are caused by bacteria, 10% by viruses and around 5% by yeasts [5]. Moulds are responsible for only 0.3% of HAI in Europe [5]. Whilst yeasticidal disinfectants are effective against yeasts, such as Candida albicans, disinfectants that are also effective against filamentous fungi or moulds, such as Aspergillus brasiliensis, are referred to as fungicidal. However, fungicidal efficacy is generally not required for hygienic hand disinfection because yeasts, unlike moulds, are transmitted via direct skin contact. Therefore, disinfectants with a yeasticidal spectrum of activity, such as Sterillium®, cover the yeasts that are relevant to hand disinfection. Essential for hand disinfection: yeasticidal activity Sources 3. S2k Guideline on Hand Disinfection and Hand Hygiene, AWMF Register No. 075-004, Class 2k guideline, as at 3 February 2023 https://register.awmf.org/assets/ guidelines/075-004l_S2k_Haendedesinfektion-und-Haendehygiene_2023-09.pdf (accessed on 18 August 2026). 4. https://www.aktion-sauberehaende.de/files/public/fileadmin/ash/user_upload/pdf/Positionspapiere/ASH_Positionspapier_15_Sekunden_01072020.pdf (accessed on 18 August 2026) 5. European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. Stockholm: ECDC; 2024. https://www.ecdc.europa.eu/sites/default/files/documents/healthcare-associated-point-prevalence-survey-acute-carehospitals-2022-2023.pdf (accessed on 18 August 2026). 6. Sakita K et al. (2017) Microb Pathog 113:225–232 18
www.hartmann-science-center.comRkJQdWJsaXNoZXIy NDU5MjM=